Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. I. Kislova"'
Autor:
M. A. Granatkin, E. A. Nikitin, M. I. Kislova, E. S. Mikhailov, V. A. Doronin, S. V. Minenko, M. M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. E. Pochtar, S. A. Lugovskaya, Yu. N. Kobzev, V. V. Ptushkin, E. V. Rimashevskaya
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 12-19 (2023)
Background. Treatment results in patients with relapsed and refractory acute myeloid leukemia (AML) remain unsatis‑factory. Treatment options for these patients are limited.Aim. To retrospectively analyze the efficacy and safety of combined therapy
Externí odkaz:
https://doaj.org/article/ef278213eaf0426fb5eff65766f77a94
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 3, Pp 91-106 (2021)
Relevance. Infections are the most common complication of chronic lymphocytic leukemia (CLL). According to registry studies, infections are the cause of death in 10–20% of patients. The emergence of new therapies for CLL has led to a decrease in mo
Externí odkaz:
https://doaj.org/article/581ae14b7528447db1958bdccd3e6ea8
Autor:
T. N. Obukhova, M. I. Kislova, E. A. Nikitin, M. A. Kislitsyna, B. V. Biderman, M. K. Tagirova, A. B. Sudarikov, V. V. Ptushkin, V. G. Savchenko
Publikováno v:
Russian journal of hematology and transfusiology. 67:75-89
Introduction. 13q14 deletion is the most common chromosomal abnormality in chronic lymphocytic leukemia (CLL), and as the sole abnormality determines the most favorable prognosis of the disease. Using molecular genetic methods two subtypes of 13q14 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cffb0633477e7bb68d46a480bd2fc43
https://doi.org/10.35754/0234-5730-2022-67-1-75-89
https://doi.org/10.35754/0234-5730-2022-67-1-75-89